Specifically, through a univariate regression analysis, we evaluated the association between risk allele carrier status for each genetic variant (OAS1/2/3, DPP9, IFNAR2, LZTFL1, ABO, and FUT2) and the development of clinical complications and of pneumonia. This evidence concerns the gene ABO and pneumonia.